rTMS shows potential for residual dizziness post-BPPV canalith repositioning, but findings should be considered preliminary; audiologists and vestibular specialists should await replication in larger RCTs before adopting this into practice.
Residual dizziness after BPPV repositioning is a common, poorly-addressed clinical problem, and if rTMS proves effective it could expand neuromodulation into vestibular rehabilitation.
- 01Residual dizziness following successful BPPV canalith repositioning affects a significant subset of patients.
- 02rTMS (repetitive transcranial magnetic stimulation) was evaluated as a non-pharmacological intervention for this symptom.
- 03Published in European Archives of Otorhinolaryngology (PMID 42062570).
- 04Findings may inform future vestibular neuromodulation protocols if replicated.
- 05Evidence level and sample size details require full-text review to confirm.
rTMS is clinically efficacious for treating residual dizziness after BPPV canalith repositioning.
studypartially supported- PMID
- 42062570
- DOI
- 10.1007/s00405-026-10198-9.
- Journal
- European Archives of Oto-Rhino-Laryngology
- Publication type
- research_article
- Evidence level
- 2b
- Population
- Patients with residual dizziness following successful BPPV canalith repositioning procedures
- Intervention
- Repetitive transcranial magnetic stimulation (rTMS)
Primary outcomes
Clinical efficacy of rTMS on residual dizziness severity; Symptom reduction after rTMS treatment